EMEA-002435-PIP01-18-M02
Key facts
| Active substance |
Eladocagene exuparvovec
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0074/2021
|
| PIP number |
EMEA-002435-PIP01-18-M02
|
| Pharmaceutical form(s) |
Solution for infusion
|
| Condition(s) / indication(s) |
Treatment of aromatic L-amino acid decarboxylase deficiency
|
| Route(s) of administration |
Intracerebral use
|
| Contact for public enquiries |
PTC Therapeutics International Limited
Tel. +353 19068700 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|